Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3351 results

Sort By:

Sublingual Buprenorphine Through Telemedicine vs In-Person Care as Usual

Study ID: NCT05339256
Start Date: 2026-02-01
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

50

Intervention / Treatment

Buprenorphine SL

Telehealth

In-person treatment as usual

Sponsor

New York State Psychiatric Institute

Source: clinicaltrials.gov

Share:
Add to list

Radicle Relief RAL™: A Study Assessing the Impact of Health and Wellness Products on Pain Relief and Related Health Outcomes

Study ID: NCT07262775
Start Date: 2026-01-04
End Date: 2027-01-04
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

715

Intervention / Treatment

Pain Relief Supplement Product Placebo Control

Pain Relief Supplement Active Product 1

Sponsor

Radicle Science

Source: clinicaltrials.gov

Share:
Add to list

Mindfulness-Based Intervention for Pediatric Mild Traumatic Brain Injury

Study ID: NCT07272941
Start Date: 2026-01
End Date: 2029-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

362

Intervention / Treatment

Mindfulness Based Intervention (MBI)

Cognitive Sham

Sponsor

Children's Hospital of Eastern Ontario

Source: clinicaltrials.gov

Share:
Add to list

Nutrition in Action: Service-Learning Project

Study ID: NCT07038031
Start Date: 2026-02-01
End Date: 2026-06-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

65

Intervention / Treatment

Promotion a food habits

Sponsor

University of Vic - Central University of Catalonia

Source: clinicaltrials.gov

Share:
Add to list

A Real-life Observational Study in Severe Eosinophilic Asthma Adult Participant Treated With Benralizumab in Italy

Study ID: NCT07214753
Start Date: 2025-12-19
End Date: 2028-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

335

Intervention / Treatment

benralizumab

Sponsor

AstraZeneca

Source: clinicaltrials.gov

Share:
Add to list

MDMA-assisted Therapy for Fibromyalgia

Study ID: NCT06066853
Start Date: 2026-01-01
End Date: 2026-12
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

20

Intervention / Treatment

MDMA

Sponsor

Spaulding Rehabilitation Hospital

Source: clinicaltrials.gov

Share:
Add to list

Effectiveness of Gamified Mobile Health Apps for Airway Clearance Therapy in Children and Adolescents With Cystic Fibrosis

Study ID: NCT06958094
Start Date: 2026-01-01
End Date: 2027-01-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

36

Intervention / Treatment

Gamified mobile health applications

Conventional Airway Clearance Therapy

Combination Treatment

Sponsor

University of Córdoba

Source: clinicaltrials.gov

Share:
Add to list

Deucravacitinib-TNF Combination Therapy for Difficult-to-Control Psoriatic Disease

Study ID: NCT07280702
Start Date: 2025-12-15
End Date: 2027-12-15
Study Type

Interventional

Study Phase

Phase4

No. of Participants

128

Intervention / Treatment

Deucravacitinib

Placebo

Sponsor

University of Texas Southwestern Medical Center

Source: clinicaltrials.gov

Share:
Add to list

A Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus.

Study ID: NCT06731075
Start Date: 2025-12-15
End Date: 2027-05-22
Study Type

Interventional

Study Phase

Phase3

No. of Participants

300

Intervention / Treatment

ORMD-0801 8 mg

Placebo capsule

ORMD-0801 16 mg

Sponsor

Oramed, Ltd.

Source: clinicaltrials.gov

Share:
Add to list

Parathyroid Allotransplant for Treatment of Hypoparathyroidism

Study ID: NCT06961071
Start Date: 2026-01-15
End Date: 2028-01-15
Study Type

Interventional

Study Phase

Phase2

No. of Participants

3

Intervention / Treatment

Parathyroid Allotransplant

Sponsor

Peter Stock

Source: clinicaltrials.gov

Share:
Add to list